Found 116 matching trials
A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection PHASE3 To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer PHASE1 The goal of this clinical trial is to evaluate the efficacy and safety of c...
Show More Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)
Learn More & Join Trial
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT N/A This multicenter retrospective study evaluated consecutive patients with la...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma PHASE2 The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Learn More & Join Trial
Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC PHASE2 This is a prospective, open-label, single-center clinical study, to evaluat...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT PHASE2 This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC EARLY_PHASE1 Lenvatinib Plus Hepatic Arterial Infusion of Modified FOLFOX Regime vs Lenv...
Show More Location
The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)
Learn More & Join Trial
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities PHASE2 This study is a prospective, randomized, single-center randomized controlle...
Show More Location
First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Postoperative Adjuvant Therapy of HCC Based on PD-1 N/A For the treatment of hepatocellular carcinoma, liver resection is still one...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial